{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:44:00Z","timestamp":1776923040716,"version":"3.51.2"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108777","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T23:06:25Z","timestamp":1752879985000},"page":"108777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanotechnology-enhanced neuroprotection: a novel idebenone nanoprodrug conjugate strategy for Parkinson's disease"],"prefix":"10.1016","volume":"163","author":[{"given":"Xinhao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108777_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116343","article-title":"5-phenyl valeric acid attenuates \u03b1-synuclein aggregation and endoplasmic reticulum stress in rotenone-induced Parkinson\u2019s disease rats: A molecular mechanistic study","volume":"226","author":"Kaur","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108777_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108777_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","article-title":"Reverse engineering Lewy bodies: how far have we come and how far can we go?","volume":"22","author":"Fares","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108777_bb0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s Disease","volume":"391","author":"Tanner Caroline","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"6357","key":"10.1016\/j.bioorg.2025.108777_bb0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108777_bb0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s11481-020-09926-7","article-title":"Neuroinflammatory responses and Parkinson\u2019 disease: pathogenic mechanisms and therapeutic targets","volume":"15","author":"Yang","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108777_bb0035","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s11064-022-03560-w","article-title":"Mitochondrial Sirtuins in Parkinson\u2019s disease","volume":"47","author":"He","year":"2022","journal-title":"Neurochem. Res."},{"issue":"s1","key":"10.1016\/j.bioorg.2025.108777_bb0040","article-title":"Therapeutic strategies for immune transformation in Parkinson\u2019s disease","volume":"12","author":"Saleh","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bioorg.2025.108777_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuint.2018.03.001","article-title":"Current perspective of mitochondrial biology in Parkinson\u2019s disease","volume":"117","author":"Ammal Kaidery","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2025.108777_bb0050","first-page":"13","article-title":"Mitochondrial dysfunction in neural injury","author":"Zhao","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108777_bb0055","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108777_bb0060","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1172\/JCI127330","article-title":"Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular \u03b1-synuclein transfer","volume":"129","author":"Musgrove","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108777_bb0065","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00415-022-11491-3","article-title":"Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"270","author":"Soraci","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.bioorg.2025.108777_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mito.2019.09.010","article-title":"Emerging concepts of mitochondrial dysfunction in Parkinson\u2019s disease progression: pathogenic and therapeutic implications","volume":"50","author":"Rani","year":"2020","journal-title":"Mitochondrion"},{"issue":"23","key":"10.1016\/j.bioorg.2025.108777_bb0075","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMct0800326","article-title":"Levodopa for the treatment of Parkinson\u2019s disease","volume":"359","author":"Lewitt Peter","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108777_bb0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mds.27386","article-title":"Motor and nonmotor complications of levodopa: phenomenology, risk factors, and imaging features","volume":"33","author":"Ray Chaudhuri","year":"2018","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108777_bb0085","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: A review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108777_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/antiox11010087","article-title":"Allicin, an antioxidant and neuroprotective agent, ameliorates cognitive impairment","volume":"11","author":"Nadeem","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108777_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240036","article-title":"Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood-brain barrier","volume":"5","author":"Wang","year":"2025","journal-title":"Exploration"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108777_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202410031","article-title":"ROS regulation in CNS disorder therapy: unveiling the dual roles of nanomedicine","volume":"21","author":"Quan","year":"2025","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108777_bb0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","article-title":"Idebenone ameliorates rotenone-induced Parkinson\u2019s disease in rats through decreasing lipid peroxidation","volume":"46","author":"Avci","year":"2020","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108777_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020484","article-title":"Idebenone Protects against Acute Murine Colitis via Antioxidant and Anti-Inflammatory Mechanisms [J\/OL]","volume":"21","author":"Shastri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108777_bb0115","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fchem.2025.1544616","article-title":"Novel idebenone derivatives attenuated oxidative stress injury and myocardial damage","volume":"13","author":"Peng","year":"2025","journal-title":"Front. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108777_bb0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00023210-199809050-00006","article-title":"Idebenone","volume":"9","author":"Adkins","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2025.108777_bb0125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.phrs.2016.07.043","article-title":"Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain","volume":"111","author":"Lauro","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108777_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-4943(90)90063-C","article-title":"Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a review","volume":"11","author":"Zs-Nagy","year":"1990","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108777_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/nano8020087","article-title":"Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy [J\/OL]","volume":"8","author":"Montenegro","year":"2018","journal-title":"Nanomaterials (Basel)"},{"issue":"187","key":"10.1016\/j.bioorg.2025.108777_bb0140","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.24976\/Discov.Med.202436187.144","article-title":"Idebenone-loaded nanocomposite microspheres for nasal administration\u2014a perspective in the treatment of Alzheimer\u2019s disease","volume":"36","author":"Pilicheva","year":"2024","journal-title":"Discov. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108777_bb0145","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/mp400170b","article-title":"Drug delivery across the blood\u2013brain barrier","volume":"10","author":"Khawli","year":"2013","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108777_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28073023","article-title":"Amphiphilic Cyclodextrin Nanoparticles as Delivery System for Idebenone: A Preformulation Study [J\/OL]","volume":"28","author":"De Gaetano","year":"2023","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108777_bb0155","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108777_bb0160","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/mds.29939","article-title":"Small particles, big potential: polymeric nanoparticles for drug delivery in Parkinson\u2019s disease","volume":"39","author":"Virameteekul","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bioorg.2025.108777_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101328","article-title":"Nanomaterials as novel agents for amelioration of Parkinson\u2019s disease","volume":"41","author":"Wu","year":"2021","journal-title":"Nano Today"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108777_bb0170","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1039\/D2CS00099G","article-title":"Degradable polyprodrugs: design and therapeutic efficiency","volume":"51","author":"Seidi","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"31","key":"10.1016\/j.bioorg.2025.108777_bb0175","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1039\/C9PY00892F","article-title":"Completely degradable backbone-type hydrogen peroxide responsive curcumin copolymer: synthesis and synergistic anticancer investigation","volume":"10","author":"Qiao","year":"2019","journal-title":"Polym. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108777_bb0180","article-title":"A whole-cell hydrogen peroxide biosensor and its application in visual food analysis. The innovation","volume":"1","author":"Gao","year":"2023","journal-title":"Life"},{"issue":"20","key":"10.1016\/j.bioorg.2025.108777_bb0185","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1021\/jm0497693","article-title":"Reversible PEGylation: A novel technology to release native interferon \u03b12 over a prolonged time period","volume":"47","author":"Peleg-Shulman","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108777_bb0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcis.2016.11.078","article-title":"Dopamine-conjugated poly(lactic-co-glycolic acid) nanoparticles for protein delivery to macrophages","volume":"490","author":"Lee","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioorg.2025.108777_bb0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","article-title":"Oxidative damage to macromolecules in human Parkinson disease and the rotenone model","volume":"62","author":"Sanders","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.108777_bb0200","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1007\/s12035-025-04824-6","article-title":"ROS regulate rotenone-induced SH-SY5Y dopamine neuron death through Ferroptosis-mediated autophagy and apoptosis","author":"Li","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2025.108777_bb0205","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s10753-024-02139-7","article-title":"The neuroprotective effects of Agmatine on Parkinson\u2019s disease: focus on oxidative stress, inflammation and molecular mechanisms","author":"Zamanian","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.bioorg.2025.108777_bb0210","first-page":"1817","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (review)","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bioorg.2025.108777_bb0215","article-title":"Alternative platelet activation pathways and their role in neurodegenerative diseases","volume":"159","author":"Ferrer-Ravent","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108777_bb0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha-Synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108777_bb0225","article-title":"Neuronal Oxidative Stress Promotes \u03b1-Synuclein Aggregation in Vivo [J\/OL]","volume":"11","author":"Won","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bioorg.2025.108777_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139436","article-title":"Hydrophobic interaction of glycitein and \u03b1-synuclein inhibits the protein aggregation: A future perspective for modulation of Parkinson\u2019s disease","volume":"296","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108777_bb0235","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1096\/fj.201903125RR","article-title":"EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson\u2019s disease","volume":"34","author":"Xu","year":"2020","journal-title":"FASEB J."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:01:07Z","timestamp":1776920467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0045206825006571"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108777","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology-enhanced neuroprotection: a novel idebenone nanoprodrug conjugate strategy for Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108777"}}